Repurposed antibiotic shows promise against Central Nervous System Tuberculosis in NUS Medicine study
Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have demonstrated that doxycycline, a commonly available and inexpensive antibiotic, can improve survival rates and neurological outcomes in Central Nervous System Tuberculosis (CNS-TB) in a preclinical non-human study. Published in the Journal of Neuroinflammation, the study offers a promising adjunctive therapy for this severe and often fatal disease.
The study, led by Associate Professor Catherine Ong ...